News

Reporting to Eric Jacobson, senior vice president and chief medical officer, Dr Vukovic will be the Synta medical leader for the company’s most advanced oncology product candidate, elesclomol,

This financing provides the company with sufficient capital to develop iCo-007 through to the completion of the Phase I clinical trial. iCo-007 is targeting the treatment of diabetic

Under the agreement, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems. Brian Hutchison, chairman and CEO of RTI, said: “We are

US president Barack Obama recently selected Mr Roosevelt as part of his transition team to co-chair a review of the social security administration. Mr Roosevelt serves as chairman

According to the company, this new technology minimizes the risk of emboli reaching the brain during critical stages of carotid artery stenting (CAS), expanding treatment options for broad

Mr Hershberg is an executive director and a board member of Powermat, a wireless electric power company that he co-founded. He is also an advisory board member of

”Despite the global economic recession, we continue to experience strong demand for our products in China since they address common everyday ailments and are reasonably priced, with consumers

Under the collaborative agreement, PacificGMP produced master cell and baculovirus banks and will provide storage services under cGMP (current good manufacturing practices) standards for LigoCyte’s norovirus vaccine program.

The agreement provides AstraZeneca with a global license for all uses of the compounds, as well as exclusive manufacturing and commercial rights. It also establishes a research collaboration